Daonil Tab.

Ingredient

Glibenclamide

Content

5mg

Indication

Type 2 diabetes (limited to cases where sufficient effect cannot be achieved with diet and exercise)

Defitelio Inj. 200mg

Ingredient

Defibrotide

Content

200mg/2.5ml

Indication

Treatment of severe hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplant (HSCT).

Depakine Chrono Tab. 300mg

Ingredient

Sodium Valproate/Valproic Acid

Content

300mg

Indication

1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
2) Treatment of manic episodes associated with bipolar disorder
-In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.

Depakine Chrono Tab. 500mg

Ingredient

Sodium Valproate/Valproic Acid

Content

500mg

Indication

1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
2) Treatment of manic episodes associated with bipolar disorder
-In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.

Dermatop Ointment/Cream/Soln. 0.25%

Ingredient

Prednicarbate

Content

2.5mg/g (Ointment and Cream), 0.25mg/100g (Solution)

Indication

Treatment of corticosteroid reactive dermatoses: Eczema, dermatitis (atopic dermatitis, seborrheic dermatitis, allergic contact dermatitis, parapsoriasis, lichen planus, prurigo), and psoriasis